Conditioned media from cancer-stimulated CAF (CAF CCM) was effective at inducing myotube atrophy in vitro, as shown by reduced myotube diameter, upregulated atrogin-1, and lower MYH2 levels. The gene discussed is FBXO32; the disease is cancer.